AIC
GMAB icon

Ameritas Investment Company’s Genmab GMAB Stock Holding History

Ameritas Investment Company’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-658
Closed -$21.6K – 1239
2021
Q1 		$21.6K Buy
+658
New +$24.7K ﹤0.01% 1260

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Ameritas Investment Company's GMAB Position: Q2 2021 in Review

Ameritas Investment Company sold out of Genmab (GMAB) in Q2 2021, closing a stake of 658 shares — an estimated $21.6K sold.

Ameritas Investment Company first reported a position in GMAB in Q1 2021 and held it in 1 quarter. The position peaked at $21.6K in Q1 2021. 213 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

  • Ameritas Investment Company reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 658 Genmab shares in Q2 2021, an estimated $21.6K.
  • Ameritas Investment Company first reported a position in Genmab in Q1 2021 and held it in 1 quarter.
  • Ameritas Investment Company's Genmab position peaked at $21.6K in Q1 2021.
  • 213 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.